Lv3
280 积分 2020-06-16 加入
Analysis of neutropenia as a predictive factor of the efficacy of trifluridine-tipiracil treatment
30天前
已关闭
Emetogenicity and Risk Factors of Nausea and Vomiting in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil and Bevacizumab Chemotherapy
30天前
已完结
The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study
30天前
已完结
An exploration of trifluridine/tipiracil in combination with irinotecan in patients with pretreated advanced gastric cancer
30天前
已完结
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis
30天前
已完结
Correction to: Efficacy and safety of trifluridine/tipiracil (TAS‑102) in patients with metastatic colorectal cancer: a systematic review and meta‑analysis
30天前
已完结
A bioequivalence study of trifluridine/tipiracil tablets in Chinese metastatic colorectal cancer patients under fed conditions
30天前
已完结
An Exploration of Trifluridine/Tipiracil Monotherapy and in Combination With Bevacizumab or Immune Checkpoint Inhibitors for Patients With Metastatic Colorectal Cancer: A Real-World Study
30天前
已完结
A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States
30天前
已完结
Comparative efficacy of later-line therapies for metastatic colorectal cancer: a network meta-analysis of survival curves
30天前
已完结
皖公网安备34019202002308
